5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.25▼ | 0.26▼ | 0.26▼ | 0.26▼ | 0.26▼ |
MA10 | 0.26▼ | 0.26▼ | 0.26▼ | 0.25▼ | 0.27▼ |
MA20 | 0.26▼ | 0.26▼ | 0.26▼ | 0.27▼ | 0.30▼ |
MA50 | 0.26▼ | 0.25▼ | 0.25▼ | 0.28▼ | 0.43▼ |
MA100 | 0.25▼ | 0.26▼ | 0.26▼ | 0.31▼ | 0.74▼ |
MA200 | 0.26▼ | 0.27▼ | 0.28▼ | 0.38▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.002▼ | -0.002▼ | 0.000▲ | 0.006▲ |
RSI | 37.162▼ | 40.009▼ | 43.144▼ | 41.903▼ | 40.772▼ |
STOCH | 14.118▼ | 3.996▼ | 13.528▼ | 45.032 | 14.396▼ |
WILL %R | -99.310▼ | -99.563▼ | -99.563▼ | -81.343▼ | -85.632▼ |
CCI | -98.053 | -111.273▼ | -125.089▼ | -48.071 | -119.261▼ |
Thursday, July 03, 2025 11:13 AM
Azitra, Inc. (NYSE American:AZTR) shareholders approved an amendment to the company’s certificate of incorporation to increase the authorized number of common shares from 100,000,000 to 200,000,000.
|
Tuesday, July 01, 2025 05:00 PM
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025. By John Vandermosten, CFA NYSE:AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2025 results in a May 13 th ...
|
Monday, June 16, 2025 05:01 PM
Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome. Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 0.26 | 0.261 | 0.245 | 0.251 | 289,900 |
02/07/25 | 0.273 | 0.273 | 0.25 | 0.255 | 725,300 |
01/07/25 | 0.259 | 0.275 | 0.255 | 0.266 | 469,400 |
30/06/25 | 0.257 | 0.27 | 0.253 | 0.261 | 735,100 |
27/06/25 | 0.254 | 0.267 | 0.247 | 0.26 | 687,200 |
26/06/25 | 0.255 | 0.265 | 0.253 | 0.262 | 747,900 |
25/06/25 | 0.249 | 0.26 | 0.24 | 0.255 | 804,300 |
24/06/25 | 0.23 | 0.26 | 0.226 | 0.25 | 1,032,400 |
23/06/25 | 0.24 | 0.243 | 0.227 | 0.233 | 1,191,900 |
20/06/25 | 0.25 | 0.255 | 0.241 | 0.247 | 1,019,100 |
|
|
||||
|
|
||||
|
|